http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101644682-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate | 2014-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101644682-B1 |
titleOfInvention | Biomarker for predicting and diagnosing drug-induced liver injury using transcriptomics and proteomics |
abstract | The present invention relates to a biomarker for predicting and diagnosing liver damage by drugs. The biomarker according to the present invention is a gene which is sensitive to liver damage by drugs and is selected through transcription and proteomics. The biomarker of the present invention is useful for predicting and diagnosing liver damage by drugs And may be useful in analyzing the type of liver damage. In addition, the biomarker according to the present invention has an advantage of quickly and accurately diagnosing and predicting the toxicity of a drug early, and thus it is possible to prevent side effects caused by toxicity caused by the drug early. |
priorityDate | 2014-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 398.